Electra Therapeutics, Inc.
ETRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002088082
In the last 90 days, Electra Therapeutics, Inc. insiders filed 3 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Electra Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
Q3 2026 data is still coming in: 7 institutions have reported holding ETRA so far. See Q3 2026
- Institutional holders
- 0
- 0 vs. Q1 2026
- Shares held
- 0
- 0 vs. Q1 2026
- Total value
- $0
- $0 vs. Q1 2026
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Electra Therapeutics, Inc.; share changes are against Q1 2026.
No institution reported holding ETRA in Q2 2026.